Literature DB >> 23414714

The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.

Ying-Xue Wang1, Ming-Long Li, Su-Guo Yu, Chang-Mei Liu, Yong Han, Xiu-Yun Wang.   

Abstract

The dysregulation of apoptosis plays a key role in carcinogenesis. This study was designed to investigate the association of apoptosis-related gene survivin A9194G single-nucleotide polymorphisms (SNPs) with papillary thyroid carcinoma (PTC) susceptibility. A case-control study of 126 patients and 198 controls was performed to investigate the association between Survivin A9194G polymorphisms and PTC susceptibility by polymerase chain reaction (PCR) following DNA sequencing methods. Moreover, the distribution of genotype frequency and the association of genotype with clinicopathologic characteristics were analyzed. We found that the survivin A9194G genotype was at a decreased risk of PTC (P=0.003; odds ratio (OR)=0.56). Furthermore, compared to the PTCs of the AA and AG phenotypes, the GG genotype thyroid cancers were significantly more common in younger patients and in cases of lower pathologic stages. In conclusion, the survivin (A9194G) polymorphism was found to play a protective role in the susceptibility to PTC. Nevertheless, further investigation with a larger sample size is needed to support our results.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414714     DOI: 10.1016/j.prp.2013.01.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  SURVIVIN POSITIVITY AND PROGNOSTIC FACTORS IN PAPILLARY THYROID CARCINOMAS.

Authors:  E Usturali Keskin; E Taştekin; N Can; A N Mut; M Celik; B Yilmaz Bulbul; F Oz Puyan; F Ozyilmaz; S Guldiken; S Ayturk; A Sezer; F Üstün
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

2.  Cyclin D1 G870A polymorphism and glioma risk in a Chinese population.

Authors:  Hao Liu; Zhi Song; Da-Guang Liao; Tian-Yi Zhang; Feng Liu; Wen Zheng; Kui Luo; Liang Yang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Survivin delta Ex3 overexpression in thyroid malignancies.

Authors:  Joanna Waligórska-Stachura; Mirosław Andrusiewicz; Nadia Sawicka-Gutaj; Maciej Biczysko; Anna Jankowska; Marta Kubiczak; Agata Czarnywojtek; Elżbieta Wrotkowska; Marek Ruchała
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

4.  Overexpression of microRNA-203 can downregulate survivin and function as a potential therapeutic target in papillary thyroid cancer.

Authors:  Xianjiang Wu; Lei Dai; Zhoujing Zhang; Jueru Zheng; Jianpei Zhao
Journal:  Oncol Lett       Date:  2019-11-13       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.